![Erik Emerson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erik Emerson
Chief Executive Officer at
GLUCOTRACK, INC.
Net worth: 458 612 $ as of 30/08/2026
Profile
Mr. Erik Emerson is a Chief Executive Officer & Director at GlucoTrack, Inc. and a Chief Executive Officer & Director at Lokahi Therapeutics, Inc. He is on the Board of Directors at GlucoTrack, Inc. and Lokahi Therapeutics, Inc. Mr. Emerson was previously employed as a President & Director by Apimeds Pharmaceuticals US, Inc., a Chief Commercial Officer by Odyssey Health, Inc., a Chief Commercial Officer by Mezzion Pharmaceuticals, Inc., a President & Chief Executive Officer by Symplmed Pharmaceuticals LLC, a Senior Director-Commercial Development by XOMA Corp., and a Marketing Director by Gilead Sciences, Inc. He also served on the board at Adhera Therapeutics, Inc. He received his undergraduate degree from the University of Oregon.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
4.97% | 14/10/2025 | 75,000 ( 4.97% ) | 291 000 $ | 30/08/2026 |
GLUCOTRACK INC 4.94% | 09/08/2026 | 39,438 ( 4.94% ) | 167 612 $ | 30/08/2026 |
Erik Emerson active positions
| Companies | Position | Start |
|---|---|---|
| GLUCOTRACK, INC. | Chief Executive Officer | 13/07/2026 |
Former positions of Erik Emerson
| Companies | Position | End |
|---|---|---|
| ODYSSEY HEALTH, INC. | Corporate Officer/Principal | 30/09/2023 |
Mezzion Pharmaceuticals, Inc.
 Mezzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug manufacturing company | Corporate Officer/Principal | 31/12/2019 |
| ADHERA THERAPEUTICS, INC. | Director/Board Member | 18/12/2019 |
Symplmed Pharmaceuticals LLC
 Symplmed Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Chief Executive Officer | 30/04/2018 |
Training of Erik Emerson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
62
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
GlucoTrack, Inc.
 GlucoTrack, Inc. Medical SpecialtiesHealth Technology Develops a non-invasive glucose monitoring device | Health Technology |
Odyssey Health, Inc.
 Odyssey Health, Inc. Medical SpecialtiesHealth Technology Develops heart monitoring and screening devices | Health Technology |
University of Oregon
 University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adhera Therapeutics, Inc.
 Adhera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes hypertensive drugs | Health Technology |
Symplmed Pharmaceuticals LLC
Symplmed Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Mezzion Pharmaceuticals, Inc.
Mezzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug manufacturing company | Health Technology |
- Stock Market
- Insiders
- Erik Emerson
